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Summary 
Chronic prenatal stress contributes to poor birth outcomes for women and infants. Importantly, poor 
birth outcomes are most common among minority and low income women. To investigate underlying 
mechanisms, we tested the hypothesis that chronic stress related to minority or low income status is 
associated with glucocorticoid resistance as indicated by disruption in the cytokine-glucocorticoid 
feedback circuit. Home visits were conducted during which 3rd trimester pregnant women completed 
stress and depression surveys and provided blood for pro- and anti-inflammatory cytokines. Saliva was 
collected 5 times the preceding day for diurnal cortisol levels. For statistical analyses, women were 
grouped 3 ways, by race, income, and the presence or absence of either of those risk factors; this last 
group was labeled high or low general risk. Immune regulation was evaluated by evidence of a 
functioning negative feedback relationship between cytokines and cortisol. Of 96 participants, 18 were 
minority, 22 of low income, and 29 either minority or low income (high general risk). Pearson partial 
correlation identified a significant negative relationship between cortisol area under the curve (AUC) 
and pro- to anti-inflammatory cytokine ratios in the low general risk women (i.e., Caucasian, higher 
income) including IFNγ/IL10 (r = −0.73, p < 0.0001), IL6/IL10 (r = −0.38, p = 0.01), IL1β/IL10 
(r = −0.44, p = 0.004) and TNFα/IL10 (r = −0.41; p = 0.005); no such correlations existed in the high 
general risk women (i.e., minority, low income) for (IFNγ/IL10: r = −0.25, p = 0.43; 
IL6/IL10: r = 0.12, p = 0.70; IL1 β/IL10: r = 0.05, p = 0.87; TNFα/IL10: r = 0.10; p = 0.75), suggestive of 
glucocorticoid resistance. Cortisol levels throughout the day also were higher in minority and high 
general risk groups (p < 0.05). Without cytokine glucocorticoid feedback, a pregnant woman's ability to 
regulate inflammation is limited, potentially contributing to adverse maternal and infant outcomes. 
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Chronic prenatal stress contributes to adverse perinatal outcomes, including preterm birth (Institute of 
Medicine, 2007), intrauterine growth retardation (Nordentoft et al., 1996), and spontaneous 
miscarriage (Institute of Medicine, 2007). Infants born premature may experience mental and physical 
disabilities that last a lifetime (Calkins and Devaskar, 2011). Even infants born at or near term whose 
mothers were exposed to prenatal stress have increased risk of abnormal neurological development 
(Davis et al., 2011, Talge et al., 2007), infectious disease (Tegethoff et al., 2011), congenital 
malformation (Tegethoff et al., 2011), poor executive functioning (Buss et al., 2011), and mood or 
behavioral disturbance (Wadhwa, 2005). Although progress has been made to clarify key mechanisms 
underlying the associations between prenatal stress and adverse pregnancy outcomes (Karrow, 
2006, Meaney et al., 2007, Sandman et al., 2011, Weaver, 2007), additional research is required to 
determine how perturbations in stress-related biological responses conspire to influence poor birth 
outcomes in high-risk populations (Kramer et al., 2011) 
With mental or physical stress, a complex neuroendocrine-immune response is initiated (Sapolsky et 
al., 2000) that includes activation of the hypothalamic-pituitary-adrenal (HPA) axis and stimulation of 
the innate immune response, leading to the increased release of pro-inflammatory cytokines (Steptoe 
et al., 2007, Yang and Glaser, 2002). This response carries benefits as well as risks for a pregnant 
woman and her offspring. Acute inflammation offers protection from infection and supports healing. 
However, even acute inflammation increases the risk of premature delivery (Romero et al., 2006) while 
chronic inflammation carries additional complications, including gestational hypertension (Freeman et 
al., 2004) and diabetes (Richardson and Carpenter, 2007). Fetal exposure to prenatal inflammation is 
also under investigation for contributions to fetal growth restriction (Almasry et al., 2012) and 
childhood diagnosis of autism (Angelidou et al., 2012). Finally, pro-inflammatory cytokines are 
associated with sickness symptoms, that include fatigue, decreased sleep, poor cognitive function, and 
depressed mood (Dantzer and Kelley, 2007), each having the potential to impact maternal health. 
Mechanisms are in place, during pregnancy (Elenkov et al., 2001) and at other times, to regulate 
inflammation including a key cytokine-glucocorticoid negative feedback circuit (Besedovsky and del 
Rey, 2006, Elenkov et al., 2005). Pro-inflammatory cytokines are potent activators of the hypothalamic-
pituitary-adrenal (HPA) axis, and contribute to stress-induced elevation in cortisol secretion. Cortisol in 
turn, is not only important in mobilizing resources to respond to the stressor, but also plays a 
fundamental role in limiting the inflammatory response and the further production of cytokines 
(Anisman and Merali, 2003, Besedovsky and del Rey, 2006, Yang and Glaser, 2002). This occurs through 
synergistic, organized mechanisms (Pace and Miller, 2009), initiated by cortisol binding to 
glucocorticoid receptors present on immune cells that are critical for regulation of the inflammatory 
response, such as monocytes and lymphocytes. Considerable evidence suggests that activation of the 
glucocorticoid receptor attenuates activity of inflammatory signaling pathways, including those that 
promote production of pro-inflammatory cytokines, while activating pathways that promote 
production of anti-inflammatory cytokines. 
In the case of chronic stress, it has been suggested that prolonged activation of the stress response can 
promote a state of glucococorticoid resistance that involves an inability of cortisol to inhibit pro-
inflammatory signaling pathways, leading to a loss of the normal negative association between cortisol 
concentration and various indicators of inflammatory immune activation (Pace et al., 2007, Stark et al., 
2001). For example, the negative correlation between plasma cortisol concentration and circulating 
leukocyte subsets seen in non-stressed individuals was lost in subjects experiencing a major chronic 
stressor during the preceding year, a finding identified as consistent with glucocorticoid resistance 
(Cohen et al., 2012). Among the mechanisms hypothesized for glucocorticoid resistance include the 
impact of stress-induced pro-inflammatory cytokine production on glucocorticoid receptor function 
(Engler et al., 2008, Raison and Miller, 2003) and that sustained elevations in cortisol in response to 
chronic stress lead to functional resistance to GR signal transduction (Miller et al., 2008). Ultimately, 
pro-inflammatory cytokine production can become dysregulated regardless of cortisol levels. 
Glucocorticoid resistance in response to chronic stress has been identified in caregivers of persons with 
cancer (Miller et al., 2008), parents of children with cancer (Miller et al., 2002), adults with a history of 
low early-life social class (Miller et al., 2009), and in women suffering post-traumatic stress syndrome 
(Pace et al., 2012a). 
Although most research on stress and inflammation has focused on non-pregnant 
individuals, Coussons-Read et al. (2005), in a study of twenty-six pregnant women, reported a positive 
correlation between self-reported stress and maternal serum levels of pro-inflammatory cytokines 
interleukin-6 (IL-6) and tumor-necrosis factor-alpha (TNF-α), and a negative correlation between stress 
and the anti-inflammatory cytokine interleukin-10 (IL-10). These findings suggested a mechanism by 
which chronic prenatal stress could be linked to adverse pregnancy outcomes. Subsequent reports by 
the same researchers furthered these findings (Coussons-Read et al., 2007), including most recently a 
report identifying a linkage between elevated serum cytokines and preterm birth (Coussons-Read et 
al., 2012). Others, however, have not confirmed a linkage between prenatal stress and either pro-or 
anti-inflammatory cytokines during pregnancy or preterm birth (Blackmore et al., 2011, Christian et al., 
2010). 
The relationship between chronic prenatal stress and adverse pregnancy outcome appears to be 
moderated by race and social class, with minority and low income women disproportionately affected 
(Institute of Medicine, 2007). After controlling for other variables (e.g., body mass index, smoking), 
minority and low income women experience worse pregnancy outcomes, including a 64% increase in 
preterm birth in African American women compared to white women (Institute of Medicine, 2007), 
and their offspring fare worse in developmental, behavioral, and physical outcomes than infants born 
to non-minority women (Reichman et al., 2008). Reproductive-age African American and low income 
women also report increased levels of stress (Paul et al., 2008), a phenomenon these authors and 
others (Dominguez, 2011, Rich-Edwards and Grizzard, 2005) ascribe to race and class discrimination. 
Identifying the underlying mechanisms by which minority status and low income adversely affect 
pregnant women and their offspring is essential. Based on the previous discussion and evidence of 
increased inflammatory responses in other populations exposed to chronic stress, we tested the 
hypothesis that minority status or low income during pregnancy (possible sources of chronic stress) 
may be associated with dysregulation in the feedback relationship between pro-inflammatory 
cytokines and cortisol. In addition, because of the effect of chronic stress on the HPA axis and the 
inflammatory response, we also hypothesized that minority status or low income would be associated 
with both increased plasma pro-inflammatory cytokine and salivary cortisol levels. 
1. Methods 
1.1. Subjects recruitment and inclusion/exclusion criteria 
The subjects were 96 women in the second or early third trimester of pregnancy who responded to ads 
placed in prenatal clinics and on community billboards. Subjects who met inclusion criteria during an 
initial phone conversation were scheduled for a home visit during their 32–36th week of pregnancy. 
Inclusion criteria were that each subject was between the ages of 18–40 years, anticipating a vaginal 
birth of a singleton fetus, in good health without pregnancy restrictions, a non-smoker, not afflicted by 
any disease that might affect the immune or endocrine systems and not taking any chronic 
medications including anti-inflammatory agents. These criteria were established to reduce to the 
extent possible conditions that might themselves be associated with inflammation or endocrine 
disorder. Subjects also were required to live within a 20 miles of the laboratory, to minimize the time 
biological samples were in transport, thereby preserving the validity of the biomarkers examined. 
1.2. Procedure 
At the start of the first home visit, the study protocol was reviewed, and participants provided 
informed consent for their participation; as a result, all procedures were carried out with the adequate 
understanding and written consent of the subjects. Participants then completed a demographic 
questionnaire detailing age, marital status, height, pre-pregnancy weight, race/ethnicity, and whether 
or not they currently were receiving government financial assistance. Self-reported height and weight 
were used to estimate pre-pregnancy body mass index (BMI). Participants were also trained to collect 
saliva samples using Salivette swabs (Sarstedt, Numbrecht, Germany). Instructions included being 
directed to rinse their mouths out with water and then place the roll-shaped saliva swab in their 
mouth, roll it around for 60 s then remove the swab and place it in the labeled tube, cap the tube, and 
place it in their home refrigerator, inside the small, padded tote provided to them. Subjects were 
additionally instructed not to eat or brush their teeth for at least half an hour before collecting saliva. 
Subjects practiced the technique with a sample swab under the observation of the research nurse, and 
then were provided the saliva collection kit. At the end of this training visit, a second home visit was 
arranged for sample collection and completion of questionnaires; this visit typically occurred within 7-
days of the training visit and lasted approximately 30 min. All sample collection visits were conducted 
by registered nurses between 3:30 and 4:30 PM to control for diurnal variability in both cortisol and 
cytokines. Subjects were compensated for both home visits. 
During the sample collection home visit, subjects provided a fresh saliva sample after which they 
completed the Perceived Stress Scale (PSS), the Edinburgh Postnatal Depression Scale (EPDS), and a 
questionnaire asking about their current health, including whether they were experiencing any 
symptoms of infection. Lastly, blood was drawn from the antecubital vein into EDTA-containing tubes 
for later measurement of plasma pro-inflammatory cytokines IL-6, IL-1β, TNF-α, and interferon-gamma 
(IFN-γ), and anti-inflammatory cytokine IL-10. In addition, on the day preceding the home visit, each 
woman collected salivary samples upon awakening, 30-min later, and at 11:00 AM, 4:00 PM, and 
8:00 PM. To encourage compliance with and accuracy of diurnal salivary collections, each subject was 
provided a study phone programmed to receive in-coming calls only, and was called the night before 
the collections were to occur, and the next day, approximately 5-min prior to each of the scheduled 
saliva collections. Subjects were compensated additionally each time they answered the phone. To 
verify the times of sample collections, the saliva swabs were kept in Medical Electronic Monitoring 
System [[MEMS®], Aprex Corp., Fremont, Calif.)] containers. Each time a sample was taken, the 
participant would have to remove the MEMS® cap, thereby recording the time of the event. Subjects 
whose sample collections were shown to have been taken at the correct times when the MEMS® cap 
data were read later in the lab, also received additional compensation. Accurate sample collection was 
defined by MEMS® cap readings within 60 min of the designated time, except for the 30-min post-
awakening sample. During the 8:00 PM phone call, subjects were reminded of the next day's visit. All 
samples were kept on ice until reaching the laboratory where they were processed as described below. 
1.3. Questionnaires 
Questionnaires included the 14-item Perceived Stress Scale (PSS) which was used to provide 
information on participants’ perception of stress (Cohen et al., 1983). The responses are based on a 
Likert-scale from 0 to 4, or from “never” to “very often.” Each question asks the individual how she has 
been feeling during the past month. The final score is a simple sum of each item response, with some 
items reverse coded. In Cohen's original report, internal consistency reliability was high (Cronbach's 
alpha coefficients ranged from 0.84–0.86) as was test-retest correlation (0.85). Evidence for concurrent 
and predictive validity was significant at p < 0.05 (r = 0.49). Scores on the PSS have been shown to 
correlate with measures of HPA axis function during pregnancy and the postpartum period (Ruiz et al., 
2003). 
The 10-item EPDS was used for self-report of symptoms of depression (Cox et al., 1987). It is an easy to 
administer and effective screening tool that has been validated for both antepartum and postpartum 
use. Answers to questions such as “I have looked forward with enjoyment to things” are scored from 0 
(“As much as I ever did”) to 4 (“Hardly at all”). After completion, a woman's score is summed to 
provide information on the likelihood of clinical depression. Validation of the EPDS against a diagnostic 
clinical interview identified a specificity of 78%, a sensitivity of 86%, and a positive predictive value of 
73% for women scoring >10 (Cox et al., 1987). 
1.4. Biomarker measurement 
Upon reaching the laboratory, blood samples were centrifuged at 4 °C for 8 min at 2000 rpm. Plasma 
aliquots were placed into 1.5 cc polypropylene microtubes and stored separately in the study lab, at 
−70° C, until assayed using a Human Pro-inflammatory Ultra-Sensitive assay and quantitative multiplex 
array technology (Meso Scale Discovery, Gaithersburg, Maryland). Intra-assay coefficient of variation 
was <5% and inter-assay coefficient of variation was <10%. The level of each cytokine is reported as 
well as the ratio of each pro-inflammatory cytokine to anti-inflammatory cytokine (e.g., IL-6/IL-10). 
Measuring the pro- to anti-inflammatory ratio is a sensitive means by which to identify cytokine 
equilibrium or disequilibrium (Petrovsky and Harrison, 1997). 
Upon reaching the laboratory, salivary samples were centrifuged at 4 °C for 3 min at 3000 rpm and 
aliquoted into 1.5 cc polypropylene microtubes for storage at the study lab at −70°C until assayed. 
Salivary cortisol levels were determined using an expanded range high sensitivity EIA kit (No. 1-3002/1-
3012, Salimetrics, State College, PA). The cortisol detection limit of the kit is .018 mg/dl and shows 
minimal cross reactivity (4% or less) with other steroids. Intra-assay coefficient of variation was 4.3% 
and inter-assay coefficient of variation was 5.2%. All samples were measured in duplicate. Area under 
the curve (AUC) was calculated with respect to ground (Pruessner et al., 2003). The cortisol awakening 
response was determined based on the difference in salivary cortisol concentration between that 
measured at awakening to that measured 30-min post-awakening according to the following formula: 
[30-min post-awakening – awakening]/awakening. 
2. Statistical analysis 
For comparative analyses, women were grouped three ways; first, as either Caucasian or of a 
racial/ethnic minority (Race), and second, as being either of high or low income (Income). These 
categories were determined by self-report of race/ethnicity and by self-report of participation in WIC 
or other government assistance programs respectively. For the third group, women were separated 
based on the presence or absence of either of the two risk factors: being minority or low income. This 
category is identified in analyses as being of high or low general risk (General Risk). Demographic and 
clinical characteristics were compared between the race, income and the general risk groups. 
Continuous variables were compared using the independent sample Student t-test. Categorical 
variables were compared using the Chi-square test or Fisher's exact test when appropriate. 
Multiple linear regression was used to assess the difference in the plasma concentrations of cytokines 
and pro- and anti-inflammatory cytokine ratios between each of the three subject groups (Race, 
Income, General Risk). Demographic and clinical variables that were significantly related to these 
groups were controlled for in the multiple linear regressions. Model-based mean and standard error 
for the cytokine measurements were derived for each subgroup. 
Linear mixed (hierarchical) models were performed on the salivary cortisol samples collected upon 
awakening, 11:00 AM, 4:00 PM, and 8:00 PM to compare the overall temporal pattern in salivary 
cortisol across the day between subject's groups. Linear mixed models were also performed on the 
salivary cortisol samples collected upon awakening and 8:30 AM to compare the cortisol awakening 
response between subject groups. An unstructured variance–covariance form in repeated 
measurements within a woman was assumed, which provides the most flexible modeling of the 
covariance structure. Subject-specific random effects were included in the mixed models to 
accommodate between-subject variation in the cortisol level. The fixed effects in the mixed models 
include subject group (Race, Income, General Risk), collection time of the sample and the interaction 
between group and the collection time. The models also include demographic and clinical variables 
that were found to be significant related to the group variable. The fitted mixed models provided 
model-based estimates for mean cortisol level at each collection time point for different subject 
groups. The differences in the temporal pattern of the cortisol between subject groups were evaluated 
by testing the significance of the interaction term between group and time. 
Pearson partial correlation coefficients were used to evaluate the association between daily average 
salivary cortisol (area under the curve [AUC], calculated using awakening, 11:00 AM, 4:00 PM, and 
8:00 PM samples) and pro- and anti-inflammatory cytokine ratios in each subject group while 
controlling for relevant demographic and clinical variables. Probability values for the partial 
correlations were computed to test the significance of the association. 
In addition to evaluating the independent effects of race and income on the levels of cytokines and 
salivary cortisol, we also performed additional statistical analyses to evaluate the interaction effects 
between race and income on the outcome measures. Specifically, we examined the significance of the 
interaction term between race and income in the multiple linear regression analyses of the plasma 
concentrations of cytokines and pro- and anti-inflammatory cytokine ratios, controlling for 
demographic and clinical variables that were significantly related to these groups. We also examined 
the significance of the interaction term between race and income on salivary cortisol in the linear 
mixed (hierarchical) models, controlling for relevant demographic and clinical variables. When there 
were significant interaction effects between race and income, model-based hypothesis tests were 
applied to evaluate the effect of income for each race group separately. 
Because the cytokine and cortisol data were right-skewed, natural log transformations were performed 
prior to the analysis and results were reported based on back transformation of the log values to the 
original scale. Statistical analysis was performed using SAS (version 9.2; SAS Institute, Cary, NC) and 
SPSS 20. All statistical tests were two-sided and a p value of <0.05 was considered statistically 
significant. 
3. Results 
Demographic data for the 96 pregnant women in this study are included in Table 1. As shown, 18 
participants self-reported minority racial or ethnic status, 11 of whom self-identified as African 
American and 7 as Hispanic. Twenty two participants reported receiving government aid. Twenty-nine 
were of minority status or reported receiving government aid and were categorized as the high general 
risk group; 66 participants were Caucasian and did not receive government aid and were categorized as 
the low general risk group. None of the participants reported or demonstrated symptoms of infection 
or illness on the day of the home visit, although four reported a physical complaint: anemia, swelling, 
allergies, or sciatica for which that woman had taken acetaminophen. With regards to birth outcomes, 
7 women delivered by Cesarean section, (7.3%); one of whom was a minority and none of whom were 
of low income; 2 women required a transfusion after delivery, both were Caucasian and neither of low 
income; and one Caucasian, non-low income woman gave birth to an infant prematurely. There were 
no statistically significant differences based on either race/ethnicity or income in these outcomes. 
Table 1. Demographic and clinical characteristics of subjects. 
 
Race  Income  General risk   
Minority Caucasian Low High High risk Low risk  
(N = 18) (N = 78) (N = 22) (N = 73) (N = 29) (N = 66)  
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Age 25.9(5.0) 29.6(4.9)** 24.1(4.5) 30.3(4.5)*** 25.7(4.8) 30.3(4.6)*** 
BMI 25.1(4.8) 23.7(3.9) 26.1(5.4) 23.4(3.4)* 25.4(5.1) 23.4(3.4)* 
PSS 20.9(7.6) 19.6(6.4) 21.6(6.6) 19.3(6.6) 21.9(7.5) 19.0(6.1)* 
EPDS 4.7(4.1) 4.4(3.3) 5.1(4.3) 4.3(3.1) 5.2(4.3) 4.2(2.9) 
Marital status N (%) N (%) p = 0.10 N (%) N (%) p < 0.0001 N (%) N (%) p = 0.001 
Other 1(5.6) 1(1.3) 2(9.1) 0(0) 2(6.9) 0(0) 
Single 3(16.7) 9(11.5) 7(31.9) 5(6.9) 7(24.1) 5(7.6) 
Married 11(61.1) 65(83.3) 10(45.5) 65(89.0) 16(55.2) 59(89.4) 
Partner 3(16.7) 3(3.9) 3(13.6) 3(4.1) 4(13.8) 2(3.0) 
Notes: values presented are mean and standard deviation (SD) or percentages (%). 
*p < 0.05. 
**p < 0.001. 
***p < .0001. 
 
As shown in Table 1, the minority group was significantly younger than the Caucasian group (p = 0.005) 
but was similar in BMI and marital status. Compared to the high income group, the low income group 
was significantly younger (p < 0.0001), had higher BMI (p = 0.04) and had significantly lower 
proportions of being married (p < 0.0001). Between the general risk groups, the high risk group was 
significantly younger (p < 0.0001), had higher BMI (p = 0.05) and had significantly lower proportions of 
being married (p = 0.001). Mean scores on the PSS were not significantly different between 
racial/ethnic groups (p = 0.47) or income groups (p = 0.17). PSS was, however, elevated in the high 
general risk group (p = 0.04). 
3.1. Salivary cortisol 
Of the more than 300 salivary samples collected, all but 2 were collected within the designated time 
and both of those were inaccurate at the 8:00 PM sampling. All analyses were run with and without 
those two samples; there were no differences in results so all samples were included in the reported 
analyses. 
Results from the linear mixed models of the salivary cortisol level are presented in Table 2 and Fig. 1. 
Subjects with low income had a significantly different temporal pattern in cortisol across the day than 
subjects with high income (p = 0.04; see Fig. 1B). There was no significant difference in the temporal 
pattern of cortisol between Caucasian and minority women, however, minority women showed a 
significantly higher level of cortisol than Caucasian women (p = 0.01; see Fig. 1A), especially in the time 
points of 11 AM (p = 0.01), 4 PM (p = 0.04) and 8 PM (p = 0.06). There was likewise no significant 
difference in the temporal pattern of cortisol between high general risk and low general risk groups. 
However, high general risk women showed a significantly higher level of cortisol than low risk women 
(p = 0.01; see Fig. 1C), again, especially in the time points of 11 AM (p = 0.001), 4 PM (p = 0.01) and 
8 PM (p = 0.02). The change in cortisol from morning awakening to 30 min after was not significantly 
different between the race groups, the income groups, or the general risk groups (Fig. 1). 
Table 2. Results of linear mixed models of salivary cortisol samples (μg/dL) for race, income and 
general risk groups. 
 
Awake 11:00 AM 4:00 PM 8:00 PM Group Time Group × time  






p value p value p value 
Minority        
 Yes 0.43(0.06) 0.41(0.04) 0.23(0.03) 0.17(0.02) 0.01 <0.0001 0.64 
 No 0.41(0.03) 0.31(0.01) 0.18(0.01) 0.13(0.01) 
   
p value for yes 
vs. no 
p = 0.79 p = 0.01 p = 0.04 p = 0.06 
   
Income        
 High 0.42(0.04) 0.30(0.03) 0.17(0.02) 0.13(0.01) 0.52 <0.0001 0.04 
 Low 0.33(0.05) 0.38(0.04) 0.20(0.02) 0.15(0.02) 
   
p value for 
high vs.low 
p = 0.14 p = 0.05 p = 0.29 p = 0.36 
   
GenRisk        
 Low 0.39(0.04) 0.27(0.02) 0.16(0.01) 0.12(0.01) 0.01 <0.0001 0.10 
 High 0.37(0.05) 0.38(0.03) 0.21(0.02) 0.16(0.02) 
   
p value for 
high vs.low 
p = 0.69 p = 0.001 p = 0.01 p = 0.02 
   
Note: values presented are model-based mean and standard error (SE) of the salivary cortisol levels 
(μg/dL). Potential confounding factors were controlled for in the linear mixed models. 
 
Figure 1. Model-based mean salivary cortisol (μg/dL) at each time point for subject subgroups. Error bars 
represent standard error of the mean. 
 
After controlling for the appropriate demographic and physical variables, the cortisol concentration in 
the salivary sample collected immediately upon arrival at the subject's homes was elevated in the 
minority women (p = 0.01) compared to the Caucasian women, in women of low compared to high SES 
(p = 0.02), and in women in the high general risk group compared to the low general risk group 
(p = 0.004). These findings were concordant with the results based on cortisol samples collected by the 
women on their own, on the day preceding the home visit. 
3.2. Pro- and anti-inflammatory cytokines 
Results based on multiple linear regression of the plasma cytokine measurements are presented 
in Table 3. After controlling for age, marital status and BMI, there were no significant differences in 
cytokine levels or cytokine ratios between the low versus high income group or between the low 
general risk versus high general risk group. When considering minority race/ethnicity, the anti-
inflammatory cytokine IL-10 was marginally lower (p = 0.09) in minority compared to Caucasian 
women. 
Table 3. Cytokine profile of subjects Mean (SE) (pg/ml). 
 
Race   Income   General risk    
Minority Caucasian p-value Low High p-value High risk Low risk p-value  
(N = 12) (N = 52) 
 
(N = 15) (N = 48) 
 
(N = 20) (N = 43) 
 
IL-1β 1.53(0.20) 1.56(0.10) 0.88 1.55(0.21) 1.22(0.17) 0.16 1.40(0.17) 1.36(0.18) 0.84 
IL-6 2.27(0.23) 2.35(0.11) 0.78 2.37(0.25) 2.37(0.26) 0.99 2.33(0.22) 2.43(0.25) 0.68 
TNFα 5.53(0.88) 7.29(0.54) 0.13 7.65(1.17) 5.94(1.06) 0.24 6.68(1.06) 6.93(1.19) 0.84 
IFNγ 1.86(0.25) 2.20(0.14) 0.28 2.02(0.30) 1.98(0.30) 0.93 1.97(0.27) 2.04(0.30) 0.80 




         
IL-1β/IL10 0.17(0.08) 0.10(0.02) 0.31 0.15(0.07) 0.06(0.03) 0.13 0.11(0.05) 0.08(0.04) 0.48 
IL-6/IL-10 0.55(0.17) 0.34(0.04) 0.16 0.40(0.14) 0.38(0.12) 0.85 0.42(0.13) 0.36(0.12) 0.63 
TNFα/IL10 1.73(0.49) 1.27(0.17) 0.32 1.70(0.51) 1.07(0.33) 0.22 1.54(0.43) 1.17(0.35) 0.37 
IFNγ/IL-10 0.40(0.20) 0.22(0.05) 0.26 0.27(0.13) 0.18(0.09) 0.48 0.26(0.12) 0.18(0.09) 0.46 
Notes: values presented are model-based mean and standard error (SE) for cytokine measurements, controlling for relevant demographic 
and clinical variables. Natural log transformations were performed on the cytokine measurements prior to the analysis and results reported 
in the table were back transformation of the log values to the usual arithmetic scale. 
3.3. Correlation between pro-inflammatory cytokine and cortisol 
After controlling for relevant demographic and physical characteristics, we identified significant 
differences in the correlations between cortisol and cytokines between women within the general risk 
group. Fig. 2 graphically displays the different patterns of association between cortisol AUC and pro- to 
anti-inflammatory cytokine ratios in this group. As shown, there were significant negative correlations 
in the low general risk women – as indicated by the negative slope (solid circles, blue lines) – between 
daily average salivary cortisol AUC and pro- to anti-inflammatory cytokine ratios including IFNγ/IL-10 
(Pearson's partial r = −0.73, p < 0.0001), IL6/IL-10 (r = −0.38, p = 0.01), IL1β/IL-10 (r = −0.44, p = 0.004), 
and TNFα/IL-10 (Pearson's partial r = −0.41; p = 0.005). In contrast, there were no negative correlations 
between any pro- to anti-inflammatory cytokine ratio and cortisol in the high general risk women 
(IFNγ/IL10: Pearson's partial r = −0.25, p = 0.43; IL6/IL10: Pearson's partial r = 0.12, p = 0.70; IL1β/IL10: 
Pearson's partial r = 0.05, p = 0.87; TNFα/IL10: Pearson's partial r = 0.10; p = 0.75), as indicated by the 
relatively flat slopes (open circles, red lines) in Fig. 2. 
 
Figure 2. Different patterns of association between cytokine and salivary cortisol in general risk groups (the 
blue/red lines represent low/high general risk groups). 
 
3.4. Interaction effects between race and income 
After controlling for relevant demographic and physical characteristics, we found significant interaction 
effects between race and income on IL1/IL10 ratio (p = 0.05). Specifically, the IL1/IL10 ratio was 
significantly higher for those with low income vs. those with high income in the minority group 
(p = 0.02). But this significant difference in IL1/IL10 ratio between low and high income women was not 
found in the Caucasian group (p = 0.66). No significant interaction effects between race and income 
were found on the salivary cortisol, controlling for relevant demographic and clinical variables 
4. Discussion 
In this report, we describe the effects of chronic social stress on the relationship between cortisol and 
the pro-inflammatory cytokines in a uniquely vulnerable population, pregnant women. The most 
significant finding is that chronic stress related to minority status or low income was associated with 
elevated cortisol without a compensatory decrease in pro-inflammatory cytokine concentration; such a 
diminished negative feedback relationship between cortisol and pro-inflammatory cytokines is 
indicative of glucocorticoid resistance. Without negative feedback, an individual's ability to regulate 
inflammation is limited. Although similar findings have been reported previously in patients with high 
lifetime trauma exposure (O’Donovan et al., 2012), in caregivers of family members with cancer (Miller 
et al., 2008, Miller et al., 2002) and in individuals with a lifetime exposure to low socioeconomic status 
(Miller et al., 2009), to our knowledge, this is the first report to identify diminished negative feedback 
as occurring in pregnant minority or low-income women. 
Diminished regulation of the inflammatory response related to chronic stress in other populations has 
been linked to glucocorticoid resistance (Cohen et al., 2012, Miller et al., 2009, Pace et al., 
2012b, Rohleder, 2012). Normally, binding of cortisol to the glucocorticoid receptor reduces WBC 
production of pro-inflammatory cytokines by inhibiting NF-kappaB (NF-κB), a transcription factor that 
regulates expression of pro-inflammatory genes (Pace et al., 2007, Pace et al., 2012a, Rohleder, 2012). 
With chronic stress, this feedback circuit becomes disrupted (Besedovsky and del Rey, 2006). Since we 
did not measure NF-κB activity we are unable to determine whether transcription factor activity was 
increased in the minority and/or low income pregnant women compared to the white or more 
economically advantaged women. The findings in this study highlight, however, the significant impact 
of poverty and minority race/ethnicity on psychoneuroimmune functioning in pregnant women and 
emphasize the need for future research in this important area. 
Also not addressed in this study is whether dysregulated inflammation was present in the minority or 
low income women before they became pregnant. Because all subjects were required to be non-
smokers with no chronic health conditions and not taking any medications or herbs on a regular basis, 
we conclude that the indicators of dysregulated inflammation likely reflect a pre-existing vulnerability, 
and are not due to disease or specific to pregnancy. This is in line with the concept of weathering 
proposed by Geronimus to explain the unique and cumulative damage to the health of African 
American women posed by racism and discrimination (Geronimus et al., 2006). In the data provided in 
this report, a biological underpinning of weathering may be visible. 
Likewise, our finding that minority status or low income was associated with elevated cortisol levels 
during pregnancy is troubling at many levels. First, chronically elevated cortisol contributes to adverse 
health conditions in non-pregnant individuals including obesity, hypertension, diabetes mellitus, and 
cancer (Seeman et al., 2010), all disproportionately present in socially and economically disadvantaged 
women (Arbour et al., 2012). In regard to pregnancy, a systematic review of the literature has 
identified clear evidence of a relationship between premature birth and elevated maternal cortisol 
levels (Giurgescu, 2009). In the current study, despite the high levels of salivary cortisol present 
throughout the day in the high risk women, pro-inflammatory cytokine levels were not decreased, 
which is explained by the finding of glucocorticoid resistance. This may be the “weathered state” that 
is a vulnerability for disease. In addition, fetal exposure to elevated HPA activity may predispose 
offspring to adulthood hypertension, obesity, and insulin resistance (Calkins and Devaskar, 2011). 
Whether these adverse effects result from fetal exposure to neuroendocrine, cardiovascular, or 
inflammatory stimuli or from epigenetic modification of the fetal brain remains under investigation 
(Sandman et al., 2011). 
Coussons-Read and colleagues (Coussons-Read et al., 2007, Coussons-Read et al., 2005) reported that 
chronic stress is associated with elevated serum IL-6 and TNF-α in pregnant women, and subsequent 
risk of preterm birth (Coussons-Read et al., 2012). Data from the present study did not find such 
elevations in cytokines after controlling for appropriate demographic and physical variables. However, 
we did find a trend toward lower levels of IL-10 in the minority women and an increase in the ratio of 
Il-1/IL-10 in the minority group only. Ultimately, given the range of biologic, behavioral, and 
socioeconomic factors that may affect cytokine levels, a larger sample size may be needed to provide 
sufficient statistical power for detecting differences in cytokine levels between groups of pregnant 
women. 
The linkages between minority status, low income, chronic social stress, and the regulation of 
inflammation, raise a host of implications when considering clinical strategies to promote health and 
the prevention of illness. If an individual is affected physiologically simply due to the fact that he or she 
is a member of a racial or ethnic minority or by being of low income, the benefits of typical prevention 
and intervention strategies may be limited. This may explain why adding a behavioral intervention to 
reduce or manage stress in African Americans with chronic disease significantly improves outcomes 
compared to usual care (Schneider et al., 2005). Lastly, since chronic inflammation has been linked to 
long term adverse health outcomes, if immune dysregulation exists outside pregnancy in minority and 
low income women, their future health may be compromised as well. 
As with all studies, there are important limitations to our findings. First, the sample was not a random 
one, but a convenience sample. Inclusion was limited to only relatively healthy women between the 
ages of 18–40 who did not smoke and were taking no chronic medications, making it difficult to 
generalize to other groups of pregnant women. Likewise, only women motivated to contact the 
research team, to follow the somewhat burdensome saliva collection protocol, and to allow a member 
of the research team to come to their homes were included. Second, only one self-report measure of 
stress was used (the PSS) that may not reflect perceived stress similarly across groups. Additionally, 
social economic status of the subjects was assessed using the dichotomized measure of whether or not 
subjects were participating in WIC, a government support program. A continuous scale of income may 
have provided a more accurate measure of the social economics status of subjects. Third, although we 
attempted to verify timing of salivary cortisol samples, and the MEMS caps’ records suggested 
accuracy for nearly all of the women nearly all of the time, there is no absolute guarantee that subjects 
did indeed collect their saliva samples at the correct time. There was, however, no indication, that 
members of one race/ethnicity or income category were more or less likely to have accurate 
collections. Fourth, the number of minority and low income participants was small, increasing the risk 
of Type 2 error. Finally, the rates of surgical births were low and there were no differences in perinatal 
outcomes between groups, both perhaps reflecting the bias of the study toward the inclusion of only 
generally healthy pregnant women. This may also reflect the younger age of the minority and low 
income women; the weathering hypothesis suggests that, at least for minority women, younger age is 
associated with lower accumulated health burden and thus better pregnancy outcomes (Geronimus, 
1996). 
In summary, our findings suggest that pregnant minority or low-income women experience 
dysregulation in the cytokine-glucocorticoid feedback circuit reflective of glucocorticoid resistance. 
Such dysregulation carries the potential for significant health risks for less advantaged women and 
their infants. Further mechanistic and interventional research into this critical area is required. 
Role of the funding source 
This study was funded by a grant to Dr. Elizabeth J. Corwin (R01NR011278) from the National Institutes 
of Health, National Institute of Nursing Research (NINR). Without their generous contribution to all 
aspects of this study (subject recruitment and compensation, data collection, bioassays, etc.) this study 
could not have been accomplished. 
Conflict of interest 
All authors report no conflict of interest to disclose, including that related to any financial, personal or 
other relationships with other people or organizations within three years of beginning the work 
submitted. 
Acknowledgements 
The research reported in this article was supported by a grant from the National Institute of Nursing 
Research, R01 NR011278, to Elizabeth J. Corwin. 
The authors thank Dr. Andrew H. Miller for his intellectual contributions to the manuscript. We also 
thank Laurel Ware, RN and Tina Fay, RN for their recruitment and data collection efforts, and Runfeng 
Jing, MD for conducting the bioassays. 
References 
Almasry et al., 2012. S.M. Almasry, M.A. Eldomiaty, A.K. Elfayomy, F.A. Habib. Expression pattern of tumor 
necrosis factor alpha in placentae of idiopathic fetal growth restriction. J. Mol. Histol., 43 (2012), 
pp. 253-261 
Angelidou et al., 2012. 
A. Angelidou, S. Asadi, K.D. Alysandratos, A. Karagkouni, S. Kourembanas, T.C. Theoharides. Perinatal 
stress, brain inflammation and risk of autism – review and proposal. BMC Pediatr., 12 (2012), p. 89 
Anisman and Merali, 2003. H. Anisman, Z. Merali. Cytokines, stress and depressive illness: brain–immune 
interactions. Ann. Med., 35 (2003), pp. 2-11 
Arbour et al., 2012. M.W. Arbour, E.J. Corwin, P.J. Salsberry, M. Atkins. Racial differences in the health of 
childbearing-aged women. MCN Am. J. Matern. Child Nurs., 37 (2012), pp. 262-268 
Besedovsky and del Rey, 2006. H.O. Besedovsky, A. del Rey. Regulating inflammation by glucocorticoids. Nat. 
Immunol., 7 (2006), p. 537 
Blackmore et al., 2011. E.R. Blackmore, J.A. Moynihan, D.R. Rubinow, E.K. Pressman, M. Gilchrist, T.G. O’Connor. 
Psychiatric symptoms and proinflammatory cytokines in pregnancy. Psychosom. Med., 73 (2011), 
pp. 656-663 
Buss et al., 2011. C. Buss, E.P. Davis, C.J. Hobel, C.A. Sandman. Maternal pregnancy-specific anxiety is 
associated with child executive function at 6–9 years age. Stress, 14 (2011), pp. 665-676 
Calkins and Devaskar, 2011. K. Calkins, S.U. Devaskar. Fetal origins of adult disease. Curr. Probl. Pediatr. Adolesc. 
Health Care, 41 (2011), pp. 158-176 
Christian et al., 2010. L.M. Christian, A. Franco, J.D. Iams, J. Sheridan, R. Glaser. Depressive symptoms predict 
exaggerated inflammatory responses to an in vivo immune challenge among pregnant women.Brain 
Behav. Immun., 24 (2010), pp. 49-53 
Cohen et al., 1983. S. Cohen, T. Kamarck, R. Mermelstein. A global measure of perceived stress. J. Health Soc. 
Behav., 24 (1983), pp. 385-396 
Cohen et al., 2012. S. Cohen, D. Janicki-Deverts, W.J. Doyle, G.E. Miller, E. Frank, B.S. Rabin, R.B. Turner. Chronic 
stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc. Natl. Acad. Sci. 
U.S.A., 109 (2012), pp. 5995-5999 
Coussons-Read et al., 2005. M.E. Coussons-Read, M.L. Okun, M.P. Schmitt, S. Giese. Prenatal stress alters 
cytokine levels in a manner that may endanger human pregnancy. Psychosom. Med., 67 (2005), 
pp. 625-631 
Coussons-Read et al., 2012. M.E. Coussons-
Read, M. Lobel, J.C. Carey, M.O. Kreither, K. D’Anna, L. Argys, R.G. Ross, C. Brandt, S. Cole. The 
occurrence of preterm delivery is linked to pregnancy-specific distress and elevated inflammatory 
markers across gestation. Brain Behav. Immun., 26 (2012), pp. 650-659 
Coussons-Read et al., 2007. M.E. Coussons-Read, M.L. Okun, C.D. Nettles. Psychosocial stress increases 
inflammatory markers and alters cytokine production across pregnancy. Brain Behav. 
Immun., 21 (2007), pp. 343-350 
Cox et al., 1987. J.L. Cox, J.M. Holden, R. Sagovsky. Detection of postnatal depression, development of the 10-
item edinburgh postnatal depression scale. Br. J. Psychiatry, 150 (1987), pp. 782-786 
Dantzer and Kelley, 2007. R. Dantzer, K.W. Kelley. Twenty years of research on cytokine-induced sickness 
behavior. Brain Behav. Immun., 21 (2007), pp. 153-160 
Davis et al., 2011. E.P. Davis, L.M. Glynn, F. Waffarn, C.A. Sandman. Prenatal maternal stress programs infant 
stress regulation. J. Child Psychol. Psychiatry, 52 (2011), pp. 119-129 
Dominguez, 2011. T.P. Dominguez. Adverse birth outcomes in African American women: the social context of 
persistent reproductive disadvantage. Soc. Work Public Health, 26 (2011), pp. 3-16 
Elenkov et al., 2005. I.J. Elenkov, D.G. Iezzoni, A. Daly, A.G. Harris, G.P. Chrousos. Cytokine dysregulation, 
inflammation and well-being. Neuroimmunomodulation, 12 (2005), pp. 255-269 
Elenkov et al., 2001. 
I.J. Elenkov, R.L. Wilder, V.K. Bakalov, A.A. Link, M.A. Dimitrov, S. Fisher, M. Crane, K.S. Kanik, G.P. Chrou
sos. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications 
for autoimmune disease activity during these times. J. Clin. Endocr. Metab., 86 (2001), pp. 4933-4938 
Engler et al., 2008. H. Engler, M.T. Bailey, A. Engler, L.M. Stiner-Jones, N. Quan, J.F. Sheridan. Interleukin-1 
receptor type 1-deficient mice fail to develop social stress-associated glucocorticoid resistance in the 
spleen. Psychoneuroendocrinology, 33 (2008), pp. 108-117 
Freeman et al., 2004. 
D.J. Freeman, F. McManus, E.A. Brown, L. Cherry, J. Norrie, J.E. Ramsay, P. Clark, I.D. Walker, N. Sattar, I.
A. Greer. Short- and long-term changes in plasma inflammatory markers associated with 
preeclampsia. Hypertension, 44 (2004), pp. 708-714 
Geronimus, 1996. A.T. Geronimus. Black/white differences in the relationship of maternal age to birthweight: 
a population-based test of the weathering hypothesis. Soc. Sci. Med., 42 (1996), pp. 589-597 
Geronimus et al., 2006. A.T. Geronimus, M. Hicken, D. Keene, J. Bound. “Weathering” and age patterns of 
allostatic load scores among blacks and whites in the United States. Am. J. Public Health, 96 (2006), 
pp. 826-833 
Giurgescu, 2009. C. Giurgescu. Are maternal cortisol levels related to preterm birth? J. Obstet. Gynecol. 
Neonatal Nurs., 38 (2009), pp. 377-390 
Institute of Medicine, 2007. Institute of Medicine, (U.S.). Committee on understanding premature birth and 
assuring healthy outcomes. R.E. Behrman, A.S. Butler (Eds.), Preterm Birth: Causes, Consequence, and 
Prevention, National Academies Press, Washington, DC (2007) 
Karrow, 2006. N.A. Karrow. Activation of the hypothalamic-pituitary-adrenal axis and autonomic nervous 
system during inflammation and altered programming of the neuroendocrine-immune axis during 
fetal and neonatal development: lessons learned from the model inflammagen, lipopolysaccharide. 
Brain Behav. Immun., 20 (2006), pp. 144-158 
Kramer et al., 2011. M.R. Kramer, C.J. Hogue, A.L. Dunlop, R. Menon. Preconceptional stress and racial 
disparities in preterm birth: an overview. Acta Obstet. Gynecol. Scand., 90 (2011), pp. 1307-1316 
Meaney et al., 2007. M.J. Meaney, M. Szyf, J.R. Seckl. Epigenetic mechanisms of perinatal programming of 
hypothalamic-pituitary-adrenal function and health. Trends Mol. Med., 13 (2007), pp. 269-277 
Miller et al., 2009. G.E. Miller, E. Chen, A.K. Fok, H. Walker, A. Lim, E.F. Nicholls, S. Cole, M.S. Kobor. Low early-
life social class leaves a biological residue manifested by decreased glucocorticoid and increased 
proinflammatory signaling. Proc. Natl. Acad. Sci. U.S.A., 106 (2009), pp. 14716-14721 
Miller et al., 2008. G.E. Miller, E. Chen, J. Sze, T. Marin, J.M. Arevalo, R. Doll, R. Ma, S.W. Cole. A functional 
genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB 
signaling. Biol. Psychiatry, 64 (2008), pp. 266-272 
Miller et al., 2002. G.E. Miller, S. Cohen, A.K. Ritchey. Chronic psychological stress and the regulation of pro-
inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol., 21 (2002), pp. 531-541 
Nordentoft et al., 1996. M. Nordentoft, H.C. Lou, D. Hansen, J. Nim, O. Pryds, P. Rubin, R. Hemmingsen. 
Intrauterine growth retardation and premature delivery: the influence of maternal smoking and 
psychosocial factors. Am. J. Public Health, 86 (1996), pp. 347-354 
O’Donovan et al., 2012. A. O’Donovan, T.C. Neylan, T. Metzler, B.E. Cohen. Lifetime exposure to traumatic 
psychological stress is associated with elevated inflammation in the Heart and Soul Study. Brain 
Behav. Immun., 26 (2012), pp. 642-649 
Pace et al., 2007. T.W. Pace, F. Hu, A.H. Miller. Cytokine-effects on glucocorticoid receptor function: relevance 
to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. 
Immun., 21 (2007), pp. 9-19 
Pace and Miller, 2009. T.W. Pace, A.H. Miller. Cytokines and glucocorticoid receptor signaling, relevance to 
major depression. Ann. N.Y. Acad. Sci., 1179 (2009), pp. 86-105 
Pace et al., 2012a. T.W. Pace, K. Wingenfeld, I. Schmidt, G. Meinlschmidt, D.H. Hellhammer, C.M. Heim. 
Increased peripheral NF-kappaB pathway activity in women with childhood abuse-related 
posttraumatic stress disorder. Brain Behav. Immun., 26 (2012), pp. 13-17 
Pace et al., 2012b. T.W.W. Pace, K. Wingenfeld, I. Schmidt, G. Meinlschmidt, D.H. Hellhammer, C.M. Heim. 
Increased peripheral NF-kappa B pathway activity in women with childhood abuse-related 
posttraumatic stress disorder. Brain Behav. Immun., 26 (2012), pp. 13-17 
Paul et al., 2008. K. Paul, D. Boutain, K. Agnew, J. Thomas, J. Hitti. The relationship between racial identity, 
income, stress and C-reactive protein among parous women: implications for preterm birth disparity 
research. J. Natl. Med. Assoc., 100 (2008), pp. 540-546 
Petrovsky and Harrison, 1997. N. Petrovsky, L.C. Harrison. Diurnal rhythmicity of human cytokine production: a 
dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J. Immunol., 158 (1997), 
pp. 5163-5168 
Pruessner et al., 2003. J.C. Pruessner, C. Kirschbaum, G. Meinlschmid, D.H. Hellhammer. Two formulas for 
computation of the area under the curve represent measures of total hormone concentration versus 
time-dependent change. Psychoneuroendocrinology, 28 (2003), pp. 916-931 
Raison and Miller, 2003. C.L. Raison, A.H. Miller. When not enough is too much: the role of insufficient 
glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiat., 160 (2003), 
pp. 1554-1565 
Reichman et al., 2008. N.E. Reichman, E.R. Hamilton, R.A. Hummer, Y.C. Padilla. Racial and ethnic disparities in 
low birthweight among urban unmarried mothers. Matern. Child Health J., 12 (2008), pp. 204-215 
Rich-Edwards and Grizzard, 2005. J.W. Rich-Edwards, T.A. Grizzard. Psychosocial stress and neuroendocrine 
mechanisms in preterm delivery. Am. J. Obstet. Gynecol., 192 (2005), pp. S30-S35 
Richardson and Carpenter, 2007. A.C. Richardson, M.W. Carpenter. Inflammatory mediators in gestational 
diabetes mellitus. Obstet. Gynecol. Clin. North Am., 34 (213–224) (2007) viii 
Rohleder, 2012. N. Rohleder. Acute and chronic stress induced changes in sensitivity of peripheral 
inflammatory pathways to the signals of multiple stress systems. 
Psychoneuroendocrinology, 37 (2012), pp. 307-316 
Romero et al., 2006. R. Romero, J. Espinoza, L.F. Goncalves, J.P. Kusanovic, L.A. Friel, J.K. Nien. Inflammation in 
preterm and term labour and delivery. Semin. Fetal Neonatal. Med., 11 (2006), pp. 317-326 
Ruiz et al., 2003. R.J. Ruiz, J. Fullerton, D.J. Dudley. The interrelationship of maternal stress, endocrine factors 
and inflammation on gestational length. Obstet. Gynecol. Surv., 58 (2003), pp. 415-428 
Sandman et al., 2011. C.A. Sandman, E.P. Davis, C. Buss, L.M. Glynn. Exposure to prenatal psychobiological 
stress exerts programming influences on the mother and her fetus. Neuroendocrinology, 95 (2011), 
pp. 8-21 
Sapolsky et al., 2000. R.M. Sapolsky, L.M. Romero, A.U. Munck. How do glucocorticoids influence stress 
responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. 
Rev., 21 (2000), pp. 55-89 
Schneider et al., 2005. R.H. Schneider, C.N. Alexander, F. Staggers, D.W. Orme-
Johnson, M. Rainforth, J.W. Salerno, W. Sheppard, A. Castillo-Richmond, V.A. Barnes, S.I. Nidich. A 
randomized controlled trial of stress reduction in African Americans treated for hypertension for over 
one year. Am. J. Hypertens., 18 (2005), pp. 88-98 
Seeman et al., 2010. T. Seeman, E. Epel, T. Gruenewald, A. Karlamangla, B.S. McEwen. Socio-economic 
differentials in peripheral biology: cumulative allostatic load. Ann. N.Y. Acad. Sci., 1186 (2010), pp. 223-
239 
Stark et al., 2001. J.L. Stark, R. Avitsur, D.A. Padgett, K.A. Campbell, F.M. Beck, J.F. Sheridan. Social stress 
induces glucocorticoid resistance in macrophages. Am. J. Physiol.: Regul. Integr. Comp. 
Physiol., 280 (2001), pp. R1799-R1805 
Steptoe et al., 2007. A. Steptoe, M. Hamer, Y. Chida. The effects of acute psychological stress on circulating 
inflammatory factors in humans: a review and meta-analysis. Brain Behav. Immun., 21 (2007), pp. 901-
912 
Talge et al., 2007. N.M. Talge, C. Neal, V. Glover. Antenatal maternal stress and long-term effects on child 
neurodevelopment: how and why? J. Child Psychol. Psyc., 48 (2007), pp. 245-261 
Tegethoff et al., 2011. M. Tegethoff, N. Greene, J. Olsen, E. Schaffner, G. Meinlschmidt. Stress during pregnancy 
and offspring pediatric disease: a national cohort study. Environ. Health Perspect., 119 (2011), 
pp. 1647-1652 
Wadhwa, 2005. P.D. Wadhwa. Psychoneuroendocrine processes in human pregnancy influence fetal 
development and health. Psychoneuroendocrinology, 30 (2005), pp. 724-743 
Weaver, 2007. I.C. Weaver. Epigenetic programming by maternal behavior and pharmacological intervention. 
Nature versus nurture: let's call the whole thing off. Epigenetics, 2 (2007), pp. 22-28 
Yang and Glaser, 2002. E.V. Yang, R. Glaser. Stress-induced immunomodulation and the implications for health. 
Int. Immunopharmacol., 2 (2002), pp. 315-324 
 
 
